Since Vanamala et al. [23] reported that IGF-1 could activate the WNT/β-catenin pathway in colon cancer, we then tested the effects of IGF-1 on activating the WNT/β-catenin pathway in glioma U87-MG cells. Here, IGF1 is linked to glioma.